Abstract

The integration of different sources of biological information about what defines a behavioral phenotype is difficult to unify in an entity that reflects the arithmetic sum of its individual parts. In this sense, the challenge of Systems Biology for understanding the “psychiatric phenotype” is to provide an improved vision of the shape of the phenotype as it is visualized by “Gestalt” psychology, whose fundamental axiom is that the observed phenotype (behavior or mental disorder) will be the result of the integrative composition of every part. Therefore, we propose the term “Gestaltomics” as a term from Systems Biology to integrate data coming from different sources of information (such as the genome, transcriptome, proteome, epigenome, metabolome, phenome, and microbiome). In addition to this biological complexity, the mind is integrated through multiple brain functions that receive and process complex information through channels and perception networks (i.e., sight, ear, smell, memory, and attention) that in turn are programmed by genes and influenced by environmental processes (epigenetic). Today, the approach of medical research in human diseases is to isolate one disease for study; however, the presence of an additional disease (co-morbidity) or more than one disease (multimorbidity) adds complexity to the study of these conditions. This review will present the challenge of integrating psychiatric disorders at different levels of information (Gestaltomics). The implications of increasing the level of complexity, for example, studying the co-morbidity with another disease such as cancer, will also be discussed.

Highlights

  • According to the World Health Organization (WHO), the frequency of psychiatric diseases has been steadily increasing (World Health Organization, 2011)

  • Despite the efforts to integrate several networks of information, it has not been possible to personalize medicine through an integrative view of the individual through different levels of information; “gestaltomics” is an unifying vision of different sources of information through a systems biology approach that is not limited to a biological understanding of the disease and instead follows an old medical principle from Hippocrates “It is far more important to know what person the disease has than what disease the person has.”

  • The ontology proposed by the Consortium of Neuropsychiatric Phenomics continues with the sequence of platforms being implemented to improve the definition of psychiatric phenotypes through different levels or domains of knowledge seeking to define a disease more accurately, including the data derived from each domain, and focusing mainly on defining the cognitive phenome of psychiatric diseases

Read more

Summary

Introduction

According to the World Health Organization (WHO), the frequency of psychiatric diseases has been steadily increasing (World Health Organization, 2011).

Objectives
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.